Women’s Health Bulletin

Published by: Kowsar

The Most Frequent HPV Genotypes in Women with Cervical Cancer in Southwest of Iran

Mojtaba Oraki Kohshour 1 , 2 , * , Manijeh Afra 1 , Abdolhossein Shakurnia 1 , Nepton Emad Mostofi 3 and Behnaz Andashti 4
Authors Information
1 Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Department of Pathology, Imam Khomeini Hospital, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Department of Genetics, School of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran
Article information
  • Women’s Health Bulletin: October 2018, 5 (4); e67230
  • Published Online: July 22, 2018
  • Article Type: Brief Report
  • Received: February 7, 2018
  • Revised: June 18, 2018
  • Accepted: June 20, 2018
  • DOI: 10.5812/whb.67230

To Cite: Oraki Kohshour M, Afra M, Shakurnia A, Emad Mostofi N, Andashti B. et al. The Most Frequent HPV Genotypes in Women with Cervical Cancer in Southwest of Iran, Women Health Bull. 2018 ; 5(4):e67230. doi: 10.5812/whb.67230.

Abstract
Copyright © 2018, Women’s Health Bulletin. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85(9):719-26. [PubMed: 18026629]. [PubMed Central: PMC2636411].
  • 2. zur Hausen H. Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta. 1996;1288(2):F55-78. [PubMed: 8876633].
  • 3. Szostek S, Klimek M, Zawilinska B, Rys J, Kope J, Daszkiewic E. Detection of human papillomavirus in cervical cell specimens by hybrid capture and PCR with different primers. Acta Biochim Pol. 2006;53(3):603-7. [PubMed: 17019439].
  • 4. Grahovac M, Racic I, Hadzisejdic I, Doric A, Grahovac B. Prevalence of human papillomavirus among Croatian women attending regular gynecological visit. Coll Antropol. 2007;31 Suppl 2:73-7. [PubMed: 17598508].
  • 5. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27. doi: 10.1056/NEJMoa021641. [PubMed: 12571259].
  • 6. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9. doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F. [PubMed: 10451482].
  • 7. Meijer CJ, Snijders PJ, Castle PE. Clinical utility of HPV genotyping. Gynecol Oncol. 2006;103(1):12-7. doi: 10.1016/j.ygyno.2006.07.031. [PubMed: 16934860].
  • 8. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. [PubMed: 20952254].
  • 9. Choi YJ, Park JS. Clinical significance of human papillomavirus genotyping. J Gynecol Oncol. 2016;27(2). e21. doi: 10.3802/jgo.2016.27.e21. [PubMed: 26768784]. [PubMed Central: PMC4717226].
  • 10. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002;287(18):2372-81. [PubMed: 11988058].
  • 11. Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288(14):1749-57. [PubMed: 12365959].
  • 12. Hamidi-Fard M, Fattahi-Abdizadeh M, Makvandi M, Ranjbari N, Mansoori E, Samarbaf-Zadeh A. Detection and Genotyping of Human Papillomavirus in Cervical Tissue Samples in Ahvaz, Southwest Iran. Jundishapur J Microbiol. 2012;6(7). doi: 10.5812/jjm.4569.
  • 13. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2(9):533-43. doi: 10.1016/S1470-2045(01)00486-7. [PubMed: 11905707].
  • 14. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol. 2000;19(1-2):1-5. [PubMed: 11091143].
  • 15. Hamkar R, Azad TM, Mahmoodi M, Seyedirashti S, Severini A, Nategh R. Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran. East Mediterr Health J. 2002;8(6):805-11. [PubMed: 15568458].
  • 16. Mahmoodi SM, Hamkaar R, Akhavantakhti M, Eslamifar A, Adibi L, Sadrabadi SAA, et al. [HPV genotypes in cervical cancer samples in Yazd province]. Iran J Infect Dis. 1997;37:19-24. Persian.
  • 17. Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J. 2010;7:65. doi: 10.1186/1743-422X-7-65. [PubMed: 20302680]. [PubMed Central: PMC2848216].
  • 18. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108. [PubMed: 15761078].
  • 19. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62. [PubMed: 11693978]. [PubMed Central: PMC2566667].
  • 20. Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015;136(2):178-82. doi: 10.1016/j.ygyno.2014.12.022. [PubMed: 25579107].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments